JRCT ID: jRCT1080220086
Registered date:12/09/2005
Basic Information
Recruitment status | |
---|---|
Health condition(s) or Problem(s) studied | Acute lung injury (ALI) associated with systemic inflammatory response syndrome (SIRS) |
Date of first enrollment | 12/09/2005 |
Target sample size | |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : Sivelestat sodium hydrate INN of investigational material : Therapeutic category code : 399 Agents affecting metabolism, n.e.c. Dosage and Administration for Investigational material : Injection |
Outcome(s)
Primary Outcome | Efficacy and safety |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | >= 18age old |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | Male and female patients with ALI associated with SIRS aged over 18 years old are included. |
Exclude criteria |
Related Information
Primary Sponsor | ONO PHARMACEUTICAL CO.,LTD. |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | JapicCTI-050088 |
Contact
Public contact | |
Name | |
Address | 06-6263-5670 |
Telephone | |
Affiliation | Ono Pharmaceutical Co., Ltd. |
Scientific contact | |
Name | |
Address | |
Telephone | |
Affiliation |